Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Antiandrogen Monotherapy market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Antiandrogen Monotherapy market. Detailed analysis of key players, along with key growth strategies adopted by Antiandrogen Monotherapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Genentech Inc. (USA)
Paladin Labs Inc. (Canada)
Sanofi-Aventis SA (France)
Novartis AG (Japan)
Immunomedics, Inc. (USA)
AstraZeneca Plc (UK)
EUSA Pharma, (USA) Inc. (USA)
Progenics Pharmaceuticals, Inc (Switzerland)
Cell Genesys Inc. (USA)
Astellas Pharma Inc (USA)
Amgen Inc (USA)
Indevus Pharmaceuticals Inc. (USA)
Medimmune, LLC (USA)
Dendreon Corporation (USA)
Abbott Laboratories. (USA)
Takeda Pharmaceutical Company Limited. (USA)
GlaxoSmithKline Plc. (USA)
F. Hoffmann-La Roche Ltd. (Switzerland)
Spectrum Pharmaceuticals, Inc. (USA)
ALZA Corporation (USA)
AstraZeneca PLC (UK)
F Hoffmann-La Roche Ltd. (USA)
By Type:
Type 1
Type 2
Type 3
By End-User:
End-User 1
End-User 2
End-User 3
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antiandrogen Monotherapy Market
-
1.3 Market Segment by Type
1.3.1 Japan Antiandrogen Monotherapy Market Size and Growth Rate of Type 1 from 2014 to 2026
1.3.2 Japan Antiandrogen Monotherapy Market Size and Growth Rate of Type 2 from 2014 to 2026
1.3.3 Japan Antiandrogen Monotherapy Market Size and Growth Rate of Type 3 from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Antiandrogen Monotherapy Market Size and Growth Rate of Application 1 from 2014 to 2026
1.4.2 Japan Antiandrogen Monotherapy Market Size and Growth Rate of Application 2 from 2014 to 2026
1.4.3 Japan Antiandrogen Monotherapy Market Size and Growth Rate of Application 3 from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Antiandrogen Monotherapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antiandrogen Monotherapy by Major Types
3.4.1 Market Size and Growth Rate of Type 1
3.4.2 Market Size and Growth Rate of Type 2
3.4.3 Market Size and Growth Rate of Type 3
4 Segmentation of Antiandrogen Monotherapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antiandrogen Monotherapy by Major End-Users
4.4.1 Market Size and Growth Rate of Antiandrogen Monotherapy in Application 1
4.4.2 Market Size and Growth Rate of Antiandrogen Monotherapy in Application 2
4.4.3 Market Size and Growth Rate of Antiandrogen Monotherapy in Application 3
5 Market Analysis by Regions
-
5.1 Japan Antiandrogen Monotherapy Production Analysis by Regions
-
5.2 Japan Antiandrogen Monotherapy Consumption Analysis by Regions
6 Hokkaido Antiandrogen Monotherapy Landscape Analysis
-
6.1 Hokkaido Antiandrogen Monotherapy Landscape Analysis by Major Types
-
6.2 Hokkaido Antiandrogen Monotherapy Landscape Analysis by Major End-Users
7 Tohoku Antiandrogen Monotherapy Landscape Analysis
-
7.1 Tohoku Antiandrogen Monotherapy Landscape Analysis by Major Types
-
7.2 Tohoku Antiandrogen Monotherapy Landscape Analysis by Major End-Users
8 Kanto Antiandrogen Monotherapy Landscape Analysis
-
8.1 Kanto Antiandrogen Monotherapy Landscape Analysis by Major Types
-
8.2 Kanto Antiandrogen Monotherapy Landscape Analysis by Major End-Users
9 Chubu Antiandrogen Monotherapy Landscape Analysis
-
9.1 Chubu Antiandrogen Monotherapy Landscape Analysis by Major Types
-
9.2 Chubu Antiandrogen Monotherapy Landscape Analysis by Major End-Users
10 Kinki Antiandrogen Monotherapy Landscape Analysis
-
10.1 Kinki Antiandrogen Monotherapy Landscape Analysis by Major Types
-
10.2 Kinki Antiandrogen Monotherapy Landscape Analysis by Major End-Users
11 Chugoku Antiandrogen Monotherapy Landscape Analysis
-
11.1 Chugoku Antiandrogen Monotherapy Landscape Analysis by Major Types
-
11.2 Chugoku Antiandrogen Monotherapy Landscape Analysis by Major End-Users
12 Shikoku Antiandrogen Monotherapy Landscape Analysis
-
12.1 Shikoku Antiandrogen Monotherapy Landscape Analysis by Major Types
-
12.2 Shikoku Antiandrogen Monotherapy Landscape Analysis by Major End-Users
13 Kyushu Antiandrogen Monotherapy Landscape Analysis
-
13.1 Kyushu Antiandrogen Monotherapy Landscape Analysis by Major Types
-
13.2 Kyushu Antiandrogen Monotherapy Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Genentech Inc. (USA)
14.1.1 Genentech Inc. (USA) Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Paladin Labs Inc. (Canada)
14.2.1 Paladin Labs Inc. (Canada) Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Sanofi-Aventis SA (France)
14.3.1 Sanofi-Aventis SA (France) Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Novartis AG (Japan)
14.4.1 Novartis AG (Japan) Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Immunomedics, Inc. (USA)
14.5.1 Immunomedics, Inc. (USA) Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 AstraZeneca Plc (UK)
14.6.1 AstraZeneca Plc (UK) Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 EUSA Pharma, (USA) Inc. (USA)
14.7.1 EUSA Pharma, (USA) Inc. (USA) Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Progenics Pharmaceuticals, Inc (Switzerland)
14.8.1 Progenics Pharmaceuticals, Inc (Switzerland) Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Cell Genesys Inc. (USA)
14.9.1 Cell Genesys Inc. (USA) Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Astellas Pharma Inc (USA)
14.10.1 Astellas Pharma Inc (USA) Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Amgen Inc (USA)
14.11.1 Amgen Inc (USA) Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 Indevus Pharmaceuticals Inc. (USA)
14.12.1 Indevus Pharmaceuticals Inc. (USA) Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
14.13 Medimmune, LLC (USA)
14.13.1 Medimmune, LLC (USA) Company Profile and Recent Development
14.13.2 Market Performance
14.13.3 Product and Service Introduction
14.14 Dendreon Corporation (USA)
14.14.1 Dendreon Corporation (USA) Company Profile and Recent Development
14.14.2 Market Performance
14.14.3 Product and Service Introduction
14.15 Abbott Laboratories. (USA)
14.15.1 Abbott Laboratories. (USA) Company Profile and Recent Development
14.15.2 Market Performance
14.15.3 Product and Service Introduction
14.16 Takeda Pharmaceutical Company Limited. (USA)
14.16.1 Takeda Pharmaceutical Company Limited. (USA) Company Profile and Recent Development
14.16.2 Market Performance
14.16.3 Product and Service Introduction
14.17 GlaxoSmithKline Plc. (USA)
14.17.1 GlaxoSmithKline Plc. (USA) Company Profile and Recent Development
14.17.2 Market Performance
14.17.3 Product and Service Introduction
14.18 F. Hoffmann-La Roche Ltd. (Switzerland)
14.18.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile and Recent Development
14.18.2 Market Performance
14.18.3 Product and Service Introduction
14.19 Spectrum Pharmaceuticals, Inc. (USA)
14.19.1 Spectrum Pharmaceuticals, Inc. (USA) Company Profile and Recent Development
14.19.2 Market Performance
14.19.3 Product and Service Introduction
14.20 ALZA Corporation (USA)
14.20.1 ALZA Corporation (USA) Company Profile and Recent Development
14.20.2 Market Performance
14.20.3 Product and Service Introduction
14.21 AstraZeneca PLC (UK)
14.21.1 AstraZeneca PLC (UK) Company Profile and Recent Development
14.21.2 Market Performance
14.21.3 Product and Service Introduction
14.22 F Hoffmann-La Roche Ltd. (USA)
14.22.1 F Hoffmann-La Roche Ltd. (USA) Company Profile and Recent Development
14.22.2 Market Performance
14.22.3 Product and Service Introduction
The List of Tables and Figures (Totals 147 Figures and 181 Tables)
Figure Japan Antiandrogen Monotherapy Market Size and Growth Rate of Type 1 from 2014 to 2026
Figure Japan Antiandrogen Monotherapy Market Size and Growth Rate of Type 2 from 2014 to 2026
Figure Japan Antiandrogen Monotherapy Market Size and Growth Rate of Type 3 from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Antiandrogen Monotherapy Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Antiandrogen Monotherapy Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Antiandrogen Monotherapy Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Antiandrogen Monotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Antiandrogen Monotherapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Antiandrogen Monotherapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antiandrogen Monotherapy by Different Types from 2014 to 2026
-
Table Consumption Share of Antiandrogen Monotherapy by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Type 1
Figure Market Size and Growth Rate of Type 2
Figure Market Size and Growth Rate of Type 3
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Antiandrogen Monotherapy by Different End-Users from 2014 to 2026
-
Table Consumption Share of Antiandrogen Monotherapy by Different End-Users from 2014 to 2026
Figure Japan Antiandrogen Monotherapy Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Antiandrogen Monotherapy Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Antiandrogen Monotherapy Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Table Japan Antiandrogen Monotherapy Production by Regions
-
Table Japan Antiandrogen Monotherapy Production Share by Regions
-
Figure Japan Antiandrogen Monotherapy Production Share by Regions in 2014
-
Figure Japan Antiandrogen Monotherapy Production Share by Regions in 2018
-
Figure Japan Antiandrogen Monotherapy Production Share by Regions in 2026
-
Table Japan Antiandrogen Monotherapy Consumption by Regions
-
Table Japan Antiandrogen Monotherapy Consumption Share by Regions
-
Figure Japan Antiandrogen Monotherapy Consumption Share by Regions in 2014
-
Figure Japan Antiandrogen Monotherapy Consumption Share by Regions in 2018
-
Figure Japan Antiandrogen Monotherapy Consumption Share by Regions in 2026
-
Table Hokkaido Antiandrogen Monotherapy Consumption by Types from 2014 to 2026
-
Table Hokkaido Antiandrogen Monotherapy Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Antiandrogen Monotherapy Consumption Share by Types in 2014
-
Figure Hokkaido Antiandrogen Monotherapy Consumption Share by Types in 2018
-
Figure Hokkaido Antiandrogen Monotherapy Consumption Share by Types in 2026
-
Table Hokkaido Antiandrogen Monotherapy Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Antiandrogen Monotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Antiandrogen Monotherapy Consumption Share by End-Users in 2014
-
Figure Hokkaido Antiandrogen Monotherapy Consumption Share by End-Users in 2018
-
Figure Hokkaido Antiandrogen Monotherapy Consumption Share by End-Users in 2026
-
Table Tohoku Antiandrogen Monotherapy Consumption by Types from 2014 to 2026
-
Table Tohoku Antiandrogen Monotherapy Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Antiandrogen Monotherapy Consumption Share by Types in 2014
-
Figure Tohoku Antiandrogen Monotherapy Consumption Share by Types in 2018
-
Figure Tohoku Antiandrogen Monotherapy Consumption Share by Types in 2026
-
Table Tohoku Antiandrogen Monotherapy Consumption by End-Users from 2014 to 2026
-
Table Tohoku Antiandrogen Monotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Antiandrogen Monotherapy Consumption Share by End-Users in 2014
-
Figure Tohoku Antiandrogen Monotherapy Consumption Share by End-Users in 2018
-
Figure Tohoku Antiandrogen Monotherapy Consumption Share by End-Users in 2026
-
Table Kanto Antiandrogen Monotherapy Consumption by Types from 2014 to 2026
-
Table Kanto Antiandrogen Monotherapy Consumption Share by Types from 2014 to 2026
-
Figure Kanto Antiandrogen Monotherapy Consumption Share by Types in 2014
-
Figure Kanto Antiandrogen Monotherapy Consumption Share by Types in 2018
-
Figure Kanto Antiandrogen Monotherapy Consumption Share by Types in 2026
-
Table Kanto Antiandrogen Monotherapy Consumption by End-Users from 2014 to 2026
-
Table Kanto Antiandrogen Monotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Antiandrogen Monotherapy Consumption Share by End-Users in 2014
-
Figure Kanto Antiandrogen Monotherapy Consumption Share by End-Users in 2018
-
Figure Kanto Antiandrogen Monotherapy Consumption Share by End-Users in 2026
-
Table Chubu Antiandrogen Monotherapy Consumption by Types from 2014 to 2026
-
Table Chubu Antiandrogen Monotherapy Consumption Share by Types from 2014 to 2026
-
Figure Chubu Antiandrogen Monotherapy Consumption Share by Types in 2014
-
Figure Chubu Antiandrogen Monotherapy Consumption Share by Types in 2018
-
Figure Chubu Antiandrogen Monotherapy Consumption Share by Types in 2026
-
Table Chubu Antiandrogen Monotherapy Consumption by End-Users from 2014 to 2026
-
Table Chubu Antiandrogen Monotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Antiandrogen Monotherapy Consumption Share by End-Users in 2014
-
Figure Chubu Antiandrogen Monotherapy Consumption Share by End-Users in 2018
-
Figure Chubu Antiandrogen Monotherapy Consumption Share by End-Users in 2026
-
Table Kinki Antiandrogen Monotherapy Consumption by Types from 2014 to 2026
-
Table Kinki Antiandrogen Monotherapy Consumption Share by Types from 2014 to 2026
-
Figure Kinki Antiandrogen Monotherapy Consumption Share by Types in 2014
-
Figure Kinki Antiandrogen Monotherapy Consumption Share by Types in 2018
-
Figure Kinki Antiandrogen Monotherapy Consumption Share by Types in 2026
-
Table Kinki Antiandrogen Monotherapy Consumption by End-Users from 2014 to 2026
-
Table Kinki Antiandrogen Monotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Antiandrogen Monotherapy Consumption Share by End-Users in 2014
-
Figure Kinki Antiandrogen Monotherapy Consumption Share by End-Users in 2018
-
Figure Kinki Antiandrogen Monotherapy Consumption Share by End-Users in 2026
-
Table Chugoku Antiandrogen Monotherapy Consumption by Types from 2014 to 2026
-
Table Chugoku Antiandrogen Monotherapy Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Antiandrogen Monotherapy Consumption Share by Types in 2014
-
Figure Chugoku Antiandrogen Monotherapy Consumption Share by Types in 2018
-
Figure Chugoku Antiandrogen Monotherapy Consumption Share by Types in 2026
-
Table Chugoku Antiandrogen Monotherapy Consumption by End-Users from 2014 to 2026
-
Table Chugoku Antiandrogen Monotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Antiandrogen Monotherapy Consumption Share by End-Users in 2014
-
Figure Chugoku Antiandrogen Monotherapy Consumption Share by End-Users in 2018
-
Figure Chugoku Antiandrogen Monotherapy Consumption Share by End-Users in 2026
-
Table Shikoku Antiandrogen Monotherapy Consumption by Types from 2014 to 2026
-
Table Shikoku Antiandrogen Monotherapy Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Antiandrogen Monotherapy Consumption Share by Types in 2014
-
Figure Shikoku Antiandrogen Monotherapy Consumption Share by Types in 2018
-
Figure Shikoku Antiandrogen Monotherapy Consumption Share by Types in 2026
-
Table Shikoku Antiandrogen Monotherapy Consumption by End-Users from 2014 to 2026
-
Table Shikoku Antiandrogen Monotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Antiandrogen Monotherapy Consumption Share by End-Users in 2014
-
Figure Shikoku Antiandrogen Monotherapy Consumption Share by End-Users in 2018
-
Figure Shikoku Antiandrogen Monotherapy Consumption Share by End-Users in 2026
-
Table Kyushu Antiandrogen Monotherapy Consumption by Types from 2014 to 2026
-
Table Kyushu Antiandrogen Monotherapy Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Antiandrogen Monotherapy Consumption Share by Types in 2014
-
Figure Kyushu Antiandrogen Monotherapy Consumption Share by Types in 2018
-
Figure Kyushu Antiandrogen Monotherapy Consumption Share by Types in 2026
-
Table Kyushu Antiandrogen Monotherapy Consumption by End-Users from 2014 to 2026
-
Table Kyushu Antiandrogen Monotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Antiandrogen Monotherapy Consumption Share by End-Users in 2014
-
Figure Kyushu Antiandrogen Monotherapy Consumption Share by End-Users in 2018
-
Figure Kyushu Antiandrogen Monotherapy Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Genentech Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech Inc. (USA)
Figure Sales and Growth Rate Analysis of Genentech Inc. (USA)
Figure Revenue and Market Share Analysis of Genentech Inc. (USA)
Table Product and Service Introduction of Genentech Inc. (USA)
Table Company Profile and Development Status of Paladin Labs Inc. (Canada)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Paladin Labs Inc. (Canada)
Figure Sales and Growth Rate Analysis of Paladin Labs Inc. (Canada)
Figure Revenue and Market Share Analysis of Paladin Labs Inc. (Canada)
Table Product and Service Introduction of Paladin Labs Inc. (Canada)
Table Company Profile and Development Status of Sanofi-Aventis SA (France)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis SA (France)
Figure Sales and Growth Rate Analysis of Sanofi-Aventis SA (France)
Figure Revenue and Market Share Analysis of Sanofi-Aventis SA (France)
Table Product and Service Introduction of Sanofi-Aventis SA (France)
Table Company Profile and Development Status of Novartis AG (Japan)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Japan)
Figure Sales and Growth Rate Analysis of Novartis AG (Japan)
Figure Revenue and Market Share Analysis of Novartis AG (Japan)
Table Product and Service Introduction of Novartis AG (Japan)
Table Company Profile and Development Status of Immunomedics, Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics, Inc. (USA)
Figure Sales and Growth Rate Analysis of Immunomedics, Inc. (USA)
Figure Revenue and Market Share Analysis of Immunomedics, Inc. (USA)
Table Product and Service Introduction of Immunomedics, Inc. (USA)
Table Company Profile and Development Status of AstraZeneca Plc (UK)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca Plc (UK)
Figure Sales and Growth Rate Analysis of AstraZeneca Plc (UK)
Figure Revenue and Market Share Analysis of AstraZeneca Plc (UK)
Table Product and Service Introduction of AstraZeneca Plc (UK)
Table Company Profile and Development Status of EUSA Pharma, (USA) Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of EUSA Pharma, (USA) Inc. (USA)
Figure Sales and Growth Rate Analysis of EUSA Pharma, (USA) Inc. (USA)
Figure Revenue and Market Share Analysis of EUSA Pharma, (USA) Inc. (USA)
Table Product and Service Introduction of EUSA Pharma, (USA) Inc. (USA)
Table Company Profile and Development Status of Progenics Pharmaceuticals, Inc (Switzerland)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals, Inc (Switzerland)
Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals, Inc (Switzerland)
Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals, Inc (Switzerland)
Table Product and Service Introduction of Progenics Pharmaceuticals, Inc (Switzerland)
Table Company Profile and Development Status of Cell Genesys Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Genesys Inc. (USA)
Figure Sales and Growth Rate Analysis of Cell Genesys Inc. (USA)
Figure Revenue and Market Share Analysis of Cell Genesys Inc. (USA)
Table Product and Service Introduction of Cell Genesys Inc. (USA)
Table Company Profile and Development Status of Astellas Pharma Inc (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc (USA)
Figure Sales and Growth Rate Analysis of Astellas Pharma Inc (USA)
Figure Revenue and Market Share Analysis of Astellas Pharma Inc (USA)
Table Product and Service Introduction of Astellas Pharma Inc (USA)
Table Company Profile and Development Status of Amgen Inc (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc (USA)
Figure Sales and Growth Rate Analysis of Amgen Inc (USA)
Figure Revenue and Market Share Analysis of Amgen Inc (USA)
Table Product and Service Introduction of Amgen Inc (USA)
Table Company Profile and Development Status of Indevus Pharmaceuticals Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indevus Pharmaceuticals Inc. (USA)
Figure Sales and Growth Rate Analysis of Indevus Pharmaceuticals Inc. (USA)
Figure Revenue and Market Share Analysis of Indevus Pharmaceuticals Inc. (USA)
Table Product and Service Introduction of Indevus Pharmaceuticals Inc. (USA)
Table Company Profile and Development Status of Medimmune, LLC (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medimmune, LLC (USA)
Figure Sales and Growth Rate Analysis of Medimmune, LLC (USA)
Figure Revenue and Market Share Analysis of Medimmune, LLC (USA)
Table Product and Service Introduction of Medimmune, LLC (USA)
Table Company Profile and Development Status of Dendreon Corporation (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon Corporation (USA)
Figure Sales and Growth Rate Analysis of Dendreon Corporation (USA)
Figure Revenue and Market Share Analysis of Dendreon Corporation (USA)
Table Product and Service Introduction of Dendreon Corporation (USA)
Table Company Profile and Development Status of Abbott Laboratories. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories. (USA)
Figure Sales and Growth Rate Analysis of Abbott Laboratories. (USA)
Figure Revenue and Market Share Analysis of Abbott Laboratories. (USA)
Table Product and Service Introduction of Abbott Laboratories. (USA)
Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited. (USA)
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited. (USA)
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited. (USA)
Table Product and Service Introduction of Takeda Pharmaceutical Company Limited. (USA)
Table Company Profile and Development Status of GlaxoSmithKline Plc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc. (USA)
Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc. (USA)
Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc. (USA)
Table Product and Service Introduction of GlaxoSmithKline Plc. (USA)
Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd. (Switzerland)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd. (Switzerland)
Table Product and Service Introduction of F. Hoffmann-La Roche Ltd. (Switzerland)
Table Company Profile and Development Status of Spectrum Pharmaceuticals, Inc. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals, Inc. (USA)
Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals, Inc. (USA)
Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals, Inc. (USA)
Table Product and Service Introduction of Spectrum Pharmaceuticals, Inc. (USA)
Table Company Profile and Development Status of ALZA Corporation (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ALZA Corporation (USA)
Figure Sales and Growth Rate Analysis of ALZA Corporation (USA)
Figure Revenue and Market Share Analysis of ALZA Corporation (USA)
Table Product and Service Introduction of ALZA Corporation (USA)
Table Company Profile and Development Status of AstraZeneca PLC (UK)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC (UK)
Figure Sales and Growth Rate Analysis of AstraZeneca PLC (UK)
Figure Revenue and Market Share Analysis of AstraZeneca PLC (UK)
Table Product and Service Introduction of AstraZeneca PLC (UK)
Table Company Profile and Development Status of F Hoffmann-La Roche Ltd. (USA)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd. (USA)
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd. (USA)
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd. (USA)
Table Product and Service Introduction of F Hoffmann-La Roche Ltd. (USA)
-
